114 related articles for article (PubMed ID: 8749837)
1. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder.
Lewis-Hall FC; Wilson MG; Tepner RG; Koke SC
J Womens Health; 1997 Jun; 6(3):337-43. PubMed ID: 9201668
[TBL] [Abstract][Full Text] [Related]
4. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
Small GW; Hamilton SH; Bystritsky A; Meyers BS; Nemeroff CB
Int Psychogeriatr; 1995; 7 Suppl():41-53. PubMed ID: 8580391
[TBL] [Abstract][Full Text] [Related]
5. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
Dalery J; Rochat C; Peyron E; Bernard G
Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
[TBL] [Abstract][Full Text] [Related]
8. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
10. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
Tollefson GD; Sayler ME
Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
[TBL] [Abstract][Full Text] [Related]
11. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
12. Double-blind pilot trial of desipramine versus fluoxetine in panic patients.
Bystritsky A; Rosen RM; Murphy KJ; Bohn P; Keys SA; Vapnik T
Anxiety; 1994-1995; 1(6):287-90. PubMed ID: 9160589
[No Abstract] [Full Text] [Related]
13. Fluoxetine (prozac) in depresion of adults.
Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
[No Abstract] [Full Text] [Related]
14. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
15. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Diaz A; Fouilloux C; Ortiz S
Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
[No Abstract] [Full Text] [Related]
16. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.
Lôo H; Saiz-Ruiz J; Costa e Silva JACE ; Ansseau M; Herrington R; Vaz-Serra A; Dilling H; de Risio S
J Affect Disord; 1999 Dec; 56(2-3):109-18. PubMed ID: 10701468
[TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
[TBL] [Abstract][Full Text] [Related]
20. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]